Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Editorial
Development of Novel HIV Vaccine by Nano-biomaterials
| Md Salahuddin1*, Md Sayfullah2, Mahjabin Rashid3, Jay Prakash Sah4, Md Abdul Momin5, Syfullah Shahriar6, Chandra Kant Yadav4, Bhupendra Sharma4, Mohammad Showkat Mahmud7 and Mohammad Alam Miah1 | |
| 1Department of Physiology, Bangladesh Agricultural University, Mymensingh-2202, Bangladesh | |
| 2College of Medicine, Shaheed Ziaur Rahman Medical College Hospital, Bogra, University of Rajshahi, Bangladesh | |
| 3College of Medicine, Mymensingh Medical College and Hospital, University of Dhaka, Mymensingh, Bangladesh | |
| 4Department of Medical Laboratory Science, School of Health and Allied Sciences, Pokhara University, Lekhnath- 12, Kaski, Nepal | |
| 5Department of microbiology and hygiene, Bangladesh Agricultural University, Mymensingh-2202, Bangladesh | |
| 6Department of Soil Science, Sher-e-Bangla Agricultural University, Dhaka-1207, Bangladesh | |
| 7Bangladesh Livestock Research Institute, Animal Health Research Division, Savar, Dhaka- 1341, Bangladesh | |
| Corresponding Author : | Md Slaahuddin Department of Physiology Bangladesh Agricultural University Mymensingh-2202, Bangladesh Tel: +8801745001875 E-mail: ssdin23@gmail.com |
| Received: May 14, 2015; Accepted: May 15, 2015; Published: May 22, 2015 | |
| Citation: Salahuddin M, Sayfullah M, Rashid M, Prakash Sah J, Abdul Momin M, et al. (2015) Development of Novel HIV Vaccine by Nano-biomaterials. Biochem Physiol 4:e136. doi:10.4172/2168-9652.1000e136 | |
| Copyright: © 2015 Salahuddin M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
Abstract
Human immune deficiency virus is a life threatening immune deficiency disease causing virus. Nowadays Nano-Medicine is a promising field for manufacturing vaccines for various bacterial and viral diseases. FPCN containing specific antigen are capable to stimulate T-cell very well to kill the viruses. P24 is the capsid protein of HIV virus which can stimulate immune response. So FPCN containing p24 will be a good choice for HIV vaccination. The present hypothesis aimed to quantify the challenges of making a novel HIV vaccine using FPCN nano-particles.
